HSA-MCM mice express tamoxifen-inducible cre in both limb and craniofacial skeletal muscles.
Karyn Esser, University of Kentucky
Genetic Background | Generation |
---|---|
N8+pN1F16
|
Allele Type |
---|
Transgenic (Recombinase-expressing, Inducible) |
Starting at:
$255.00 Domestic price for female 4-week |
333.51 Domestic price for breeder pair |
HSA-MCM mice express MerCreMer double fusion protein under the control of the human ACTA1 (actin, alpha 1, skeletal muscle) promoter. Heterozygous mice are viable and fertile. Homozygotes are also viable but exhibit significanly reduced fertility. Of note, the MerCreMer double fusion protein has substantially greater Cre recombinase activity with less promiscuity compared with the CreMer single fusion protein. When HSA-MCM mice are bred with mice containing loxP-flanked sequences, tamoxifen-inducible Cre-mediated recombination is expected to result in deletion of the floxed sequences in skeletal muscles of the limbs, face/tongue, and diaphragm of the offspring.
When cre mice are treated with tamoxifen and then fed a high fat diet, glucose tolerance and circulating insulin levels are significantly improved. [Batran et al. Diabetologia June 2018].
The MerCreMer double fusion protein consists of Cre recombinase flanked on each end with a mutated murine estrogen receptor (mer) ligand binding domain (amino acids 281-599, G525R); which does not bind its natural ligand (17β-estradiol) at physiological concentrations but will bind the synthetic estrogen receptor ligands 4-hydroxytamoxifen (OHT or tamoxifen) and, with lesser sensitivity, ICI 182780. Restricted to the cytoplasm, MerCreMer can only gain access to the nuclear compartment after exposure to tamoxifen. To counteract the mixed estrogen agonist effects of tamoxifen injections, which can result in late fetal abortions in pregnant mice, progesterone may be coadministered.
A transgenic construct was designed to contain a MerCreMer sequence under the control of the human ACTA1 (actin, alpha 1, skeletal muscle) promoter. The MerCreMer double fusion protein has a Cre recombinase cDNA sequence flanked on each end with a mutated murine estrogen receptor (mer) ligand binding domain (amino acids 281-599, G525R); thus rendering cre expression tamoxifen-inducible yet estrogen-insensitive. A β-globin intron II sequence, followed by a polyadenylation sequence, was inserted downstream of the promoter to ensure proper splicing. This HSA-MCM transgene was introduced into (C57BL/6 X C3H)F2 donor oocytes. The donating investigator reports that the resulting offspring from founder line 2 were bred to C57BL/6J mice for at least 8 generations (see SNP note below). Upon arrival at The Jackson Laboratory, mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. Two of the 27 markers throughout the genome were segregating suggesting an incomplete backcross. Also, all 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed genetic background.
Expressed Gene | cre/Esr1, Cre recombinase and estrogen receptor 1 fusion gene, |
---|---|
Site of Expression | When mice carrying this transgne are bred with mice containing loxP-flanked sequences, tamoxifen-inducible Cre-mediated recombination is expected to result in deletion of the floxed sequences in skeletal muscles of the limbs, face/tongue, and diaphragm of the offspring. |
Allele Name | transgene insertion 2, Karyn A Esser |
---|---|
Allele Type | Transgenic (Recombinase-expressing, Inducible) |
Allele Synonym(s) | HSA-MCM; HSA-MerCreMer |
Gene Symbol and Name | Tg(ACTA1-cre/Esr1*)2Kesr, transgene insertion 2, Karyn A Esser |
Gene Synonym(s) | |
Promoter | ACTA1, actin, alpha 1, skeletal muscle, human |
Expressed Gene | cre/Esr1, Cre recombinase and estrogen receptor 1 fusion gene, |
Site of Expression | When mice carrying this transgne are bred with mice containing loxP-flanked sequences, tamoxifen-inducible Cre-mediated recombination is expected to result in deletion of the floxed sequences in skeletal muscles of the limbs, face/tongue, and diaphragm of the offspring. |
Strain of Origin | (C57BL/6 x C3H)F2 |
Chromosome | UN |
Molecular Note | The human alpha-skeletal actin gene promoter (ACTA1; HSA) was cloned into a vector upstream the cre recombinase gene fused at the N- and C-termini to mutated estrogen receptor ligand-binding domains (MerCreMer). A beta-globin intron II sequence followed by a polyadenylation sequence were inserted downstream of the promoter to ensure proper splicing. The construct was injected into B6C3F2 embryos. Five founders were generated and crossed to Rosa-lacz reporter mice to assess germline transmission and inducible muscle-specific recombinase activity. Line 2 was established. |
When maintaining live mice, hemizygotes may be bred together. Homozygous mice are viable but have significantly reduced fertility.
When using the HSA-MCM mouse strain in a publication, please cite the originating article(s) and include JAX stock #025750 in your Materials and Methods section.
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(ACTA1-cre/Esr1*)2Kesr |
Frozen Mouse Embryo | STOCK Tg(ACTA1-cre/Esr1*)2Kesr/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(ACTA1-cre/Esr1*)2Kesr/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(ACTA1-cre/Esr1*)2Kesr/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Tg(ACTA1-cre/Esr1*)2Kesr/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.